UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

YKL-40 in allogeneic hematopoietic cell transplantation after acute myeloid leukemia and myelodysplastic syndrome

Bone marrow transplantation (Basingstoke), 2016-07, Vol.51 (12), p.1556-1560

2016

Volltextzugriff (PDF)

The Prognostic Value of YKL-40 in Allogeneic Hematopoietic Cell Transplantation

Blood, 2014-12, Vol.124 (21), p.1176-1176

2014

Volltextzugriff (PDF)

Correction: MHC Class II Tetramers Made from Isolated Recombinant α and β Chains Refolded with Affinity-Tagged Peptides

PloS one, 2013-12, Vol.8 (12)

2013

Volltextzugriff (PDF)

Correction: MHC Class II Tetramers Made from Isolated Recombinant α and β Chains Refolded with Affinity-Tagged Peptides

PloS one, 2013-09, Vol.8 (9)

2013

Volltextzugriff (PDF)

Identification and HLA-tetramer-validation of human [CD4.sup.+] and [CD8.sup.+] T cell responses against HCMV proteins IE1 and IE2

PloS one, 2014-04, Vol.9 (4)

2014

Volltextzugriff (PDF)

Impact of Postremission Consolidation Chemotherapy On Outcome After Reduced-Intensity Conditioning (RIC) Allogeneic Stem Cell Transplantation (allo-SCT) for AML in First Complete Remission (CR1): A Report From the Acute Leukemia Working Party of EBMT

Blood, 2012-11, Vol.120 (21), p.3098-3098

2012

Volltextzugriff (PDF)

Impact of Chronic Graft-Versus-Host disease (GVHD) After Reduced Intensity Conditioning (RIC) Allogeneic Stem Cell Transplantation (allo-SCT) As Treatment for Acute Myeloid Leukemia (AML): A Survey From the Acute Leukemia Working Party of the EBMT

Blood, 2011-11, Vol.118 (21), p.321-321

2011

Volltextzugriff (PDF)

Association of HMGB1 Polymorphisms with Outcome After Allogeneic Hematopoietic Cell Transplantation

Blood, 2009-11, Vol.114 (22), p.2260-2260

2009

Volltextzugriff (PDF)

Genetic Variation in AKAP13 Is Associated with Increased Risk of Relapse after Allogeneic Hematopoietic Cell Transplantation Following Non-Myeloablative Conditioning

Blood, 2008-11, Vol.112 (11), p.3257-3257

2008

Volltextzugriff (PDF)

The PTPN22 1858C/T Polymorphism Is Associated with the Development of Grade 3 to 4 Acute Graft-Versus-Host Disease after Allogeneic Hematopoietic Cell Transplantation Following Nonmyeloablative Conditioning

Blood, 2007-11, Vol.110 (11), p.1969-1969

2007

Volltextzugriff (PDF)

Cytokine Gene Expression in Peripheral Blood Mononuclear Cells Points to Interleukin-10 as an Inhibitor of Alloreactivity Following Hematopoietic Cell Transplantation with Nonmyeloablative Conditioning

Blood, 2005-11, Vol.106 (11), p.5342-5342

2005

Volltextzugriff (PDF)

The Predictive Value of Gene Expression Profiles for Acute Graft-Versus-Host Disease after Hematopoietic Cell Transplantation with Nonmyeloablative Conditioning for Hematological Malignancy

Blood, 2007-11, Vol.110 (11), p.1079-1079

2007

Volltextzugriff (PDF)

Kinetics of Early Donor Chimerism after Nonmyeloablative Haematopoietic Stem Cell Transplantation Monitored with High-Resolution Real Time Quantitative PCR

Blood, 2005-11, Vol.106 (11), p.3669-3669

2005

Volltextzugriff (PDF)

Correlates with Clinical Outcome after Myeloablative or Nonmyeloablative Allogeneic Hematopoietic Cell Transplantation

PloS one, 2016-12, Vol.11 (12), p.e0168210

2016

Volltextzugriff (PDF)

Evidence for Involvement of Clonally Expanded CD8+ T Cells in Anti-Cancer Immune Responses in CLL Patients Following Nonmyeloablative Conditioning and Hematopoietic Cell Transplantation (HCT)

Blood, 2005-11, Vol.106 (11), p.1260-1260

2005

Volltextzugriff (PDF)

Non-Myeloablative Allogeneic Hematopoietic Stem Cell Transplantation in Hodgkin's Disease

Biology of blood and marrow transplantation, 2015-02, Vol.21 (2), p.S197-S197

2015

Volltextzugriff (PDF)

MHC Class II Tetramers Made from Isolated Recombinant [alpha] and [beta] Chains Refolded with Affinity-Tagged Peptides

PloS one, 2013-09, Vol.8 (9), p.e73648

2013

Volltextzugriff (PDF)

Close Monitoring of Cyclosporine A Concentration as a Means of Preventing Acute Graft-Versus-Host Disease in Allogeneic Stem Cell Recipients

Biology of blood and marrow transplantation, 2014-02, Vol.20 (2), p.S277-S277

2014

Volltextzugriff (PDF)

A randomized trial comparing busulfan with total body irradiation as conditioning in allogeneic marrow transplant recipients with leukemia: a report from the Nordic Bone Marrow Transplantation Group

Blood, 1994-05, Vol.83 (9), p.2723-2730

1994

Volltextzugriff (PDF)

Novel Immunodominant CD4+ T Cell Epitopes in the CMV Proteins IE1 and IE2

Biology of blood and marrow transplantation, 2013-02, Vol.19 (2), p.S195-S195

2013

Volltextzugriff (PDF)

1 – 25 von 44

Suche als RSS-Feed

Aktive Filter

ThemaHumans

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(35)
Mit Volltextzugriff
(40)

Publikationsform

Sprache

Englisch
(44)

Erscheinungsjahr

n.n

Menü

Weitere Dienste

Einstellungen

YKL-40 in allogeneic hematopoietic cell transplantation after acute myeloid leukemia and myelodysplastic syndrome

The Prognostic Value of YKL-40 in Allogeneic Hematopoietic Cell Transplantation

Correction: MHC Class II Tetramers Made from Isolated Recombinant α and β Chains Refolded with Affinity-Tagged Peptides

Correction: MHC Class II Tetramers Made from Isolated Recombinant α and β Chains Refolded with Affinity-Tagged Peptides

Identification and HLA-tetramer-validation of human [CD4.sup.+] and [CD8.sup.+] T cell responses against HCMV proteins IE1 and IE2

Impact of Postremission Consolidation Chemotherapy On Outcome After Reduced-Intensity Conditioning (RIC) Allogeneic Stem Cell Transplantation (allo-SCT) for AML in First Complete Remission (CR1): A Report From the Acute Leukemia Working Party of EBMT

Equivalent Outcome Between Older Siblings and Unrelated Donors After Reduced Intensity Allogeneic Hematopoietic Stem Cell Transplantation for Patients Older Than 50 Years with Acute Myeloid Leukemia in First Complete Remission: A Report From the ALWP of EBMT

Impact of Chronic Graft-Versus-Host disease (GVHD) After Reduced Intensity Conditioning (RIC) Allogeneic Stem Cell Transplantation (allo-SCT) As Treatment for Acute Myeloid Leukemia (AML): A Survey From the Acute Leukemia Working Party of the EBMT

Association of HMGB1 Polymorphisms with Outcome After Allogeneic Hematopoietic Cell Transplantation

Genetic Variation in AKAP13 Is Associated with Increased Risk of Relapse after Allogeneic Hematopoietic Cell Transplantation Following Non-Myeloablative Conditioning

The PTPN22 1858C/T Polymorphism Is Associated with the Development of Grade 3 to 4 Acute Graft-Versus-Host Disease after Allogeneic Hematopoietic Cell Transplantation Following Nonmyeloablative Conditioning

Impacts of Cytogenetic Abnormalities and Prior Alemtuzumab on Outcomes of Patients (pts) with High-Risk Chronic Lymphocytic Leukemia (CLL) Given Nonmyeloablative Allogeneic Hematopoietic Cell Transplantation (HCT)

Mobilized peripheral blood stem cells compared with bone marrow from HLA ‐identical siblings for reduced‐intensity conditioning transplantation in acute myeloid leukemia in complete remission: a retrospective analysis from the A cute Leukemia W orking P arty of EBMT

Cytokine Gene Expression in Peripheral Blood Mononuclear Cells Points to Interleukin-10 as an Inhibitor of Alloreactivity Following Hematopoietic Cell Transplantation with Nonmyeloablative Conditioning

The Predictive Value of Gene Expression Profiles for Acute Graft-Versus-Host Disease after Hematopoietic Cell Transplantation with Nonmyeloablative Conditioning for Hematological Malignancy

Kinetics of Early Donor Chimerism after Nonmyeloablative Haematopoietic Stem Cell Transplantation Monitored with High-Resolution Real Time Quantitative PCR

Nonmyeloablative Allogeneic Hematopoietic Cell Transplantation in Patients with De Novo and Secondary Acute Myeloid Leukemia

Correlates with Clinical Outcome after Myeloablative or Nonmyeloablative Allogeneic Hematopoietic Cell Transplantation

Evidence for Involvement of Clonally Expanded CD8+ T Cells in Anti-Cancer Immune Responses in CLL Patients Following Nonmyeloablative Conditioning and Hematopoietic Cell Transplantation (HCT)

Non-Myeloablative Allogeneic Hematopoietic Stem Cell Transplantation in Hodgkin's Disease

MHC Class II Tetramers Made from Isolated Recombinant [alpha] and [beta] Chains Refolded with Affinity-Tagged Peptides

Close Monitoring of Cyclosporine A Concentration as a Means of Preventing Acute Graft-Versus-Host Disease in Allogeneic Stem Cell Recipients

A randomized trial comparing busulfan with total body irradiation as conditioning in allogeneic marrow transplant recipients with leukemia: a report from the Nordic Bone Marrow Transplantation Group

Novel Immunodominant CD4+ T Cell Epitopes in the CMV Proteins IE1 and IE2

Aktive Filter

Suchergebnisse filtern